Technological Advancements
The neurovascular devices market has witnessed significant technological advancements in the past few years. Manufacturers are focusing on developing minimally invasive and effective neurovascular devices to treat various neurological disorders. Some of the key technological developments include high resolution and 3D imaging capabilities, advanced coil and stent designs, flow diversion stents, and pipeline embolization devices.
3D imaging and navigation systems have improved surgical precision and safety during neurovascular procedures. Neurovascular Devices equipped with these technologies provide real-time, high resolution images of the vascular anatomy, blood flow, and placement of devices during interventions. This helps surgeons perform complex procedures with minimally invasive approaches.
Coil and stent designs have also evolved significantly. Newer coil designs are more conformable and detachable to effectively occlude aneurysms. Stents have improved radial strength, flexibility and visibility under imaging. Flow diversion stents with ultra-high metal coverage are being used increasingly for treating large and giant aneurysms. These stents are designed to divert blood flow away from the aneurysm, eventually causing it to thrombose.
Pipeline embolization devices are emerging as an alternative treatment for some large or giant wide-neck aneurysms that cannot be coiled. These flexible, self-expanding, nitinol mesh tubes are delivered through a microcatheter into the aneurysm. Over time, they promote healing of the parent vessel while completely occluding the aneurysm.
Rising Prevalence of Neurological Disorders Fuels Market Growth
The rapid rise in the global prevalence of neurological disorders such as stroke, brain aneurysms, arteriovenous malformations (AVM), and spinal cord injuries is a key driver for the neurovascular devices market. According to various estimates, over 17 million people suffer a stroke worldwide each year. Brain aneurysms affect over 30,000 people in the U.S. annually. Genetic predisposition, lifestyle factors such as smoking and obesity, and aging populations are contributing to the increasing disease burden.
Neurovascular procedures are often minimally invasive alternatives to neurosurgeries with lower risk and faster recovery times. Growing awareness about treatment options and technological advancements are prompting more patients to opt for minimally invasive interventions. This is boosting the adoption of advanced neurovascular devices among healthcare facilities globally. Favorable medical reimbursement policies for minimally invasive procedures in developed nations also support market revenues.
Expanding Product Portfolios of Key Players
To capitalize on growth opportunities, leading neurovascular device manufacturers are enhancing and expanding their product portfolios. Several companies have undertaken strategic acquisitions to add new device platforms and technologies to their offerings. For example, in 2021, Medtronic acquired Aneurx to strengthen its portfolio of aneurysm treatment solutions with the Nellix endovascular aneurysm sealing system.
Stryker acquired Wright Medical’s neurovascular business in 2021 to gain access to thePipeline embolization device and Synchron family of flow diversion stents. Meanwhile, Balt has expanded into new neurovascular therapies after the acquisition of Optis in 2018 which added the Flow Redirection Endoluminal Device (FRED) to its product lines.
Such acquisitions and collaborations allow companies to broaden clinical indications and become one-stop-shops for a range of neurovascular interventions. This helps consolidate their market positions and better serve the growing needs of healthcare facilities worldwide. Looking ahead, neurovascular device makers are expected to develop innovative solutions that advance minimally invasive techniques and improve patient outcomes.
Asia Pacific and Latin America Offer High Growth Potential
While North America and Europe currently dominate the neurovascular devices landscape, the Asia Pacific and Latin American markets are identified as high growth regions. Rapid economic development, rising healthcare investments, growing disease awareness, and expanding health insurance coverage are driving the neurovascular procedures market in developing Asian countries like China, India and Japan.
An aging population prone to neurological disorders also contributes to demand growth. In China alone, the number of individuals aged 65 years and older is projected to grow from 125 million in 2017 to 248 million by 2050. This will substantially increase the need for neurovascular care. Latin American countries are witnessing similar demographical shifts that are escalating the disease burden. Increased accessibility of advanced technologies at affordable costs makes neurovascular interventions a viable treatment option in emerging markets.
Leading suppliers are strengthening their presence in Asia Pacific and Latin America through collaborations with local distributors and clinical education programs. This allows them to tap rising demand from cash-pay healthcare markets and push adoption of their innovative products. With strong socio-economic trends supporting market expansion, the Asia Pacific and Latin America neurovascular devices landscapes will likely witness exponential growth over the next decade.
The global neurovascular devices market has tremendous prospects driven by the growing prevalence of neurological disorders and shifting treatment trends toward minimally invasive interventions. Technological advancements are widening clinical applications while expanding product portfolios enable companies to offer complete neurovascular care. Favorable reimbursement policies in developed nations and rapid infrastructure development in developing regions will sustain market growth. Looking ahead, Asia Pacific and Latin America neurovascular markets are primed to emerge as major revenue generators with substantial untapped opportunities.
Get more insights on Neurovascular Devices
Comments
0 comment